(Q34510279)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817043%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

review article

1 reference

title

Antitumor drugs possessing topoisomerase I inhibition: applicable separation methods (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817043%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

T Oguma

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817043%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817043%20AND%20SRC:MED&resulttype=core&format=json

Journal of Chromatography B: Biomedical Sciences and Applications

6 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817043%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

volume

764

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817043%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817043%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

page(s)

49-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817043%20AND%20SRC:MED&resulttype=core&format=json

Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2

6 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Determination of camptothecin analogs in biological matrices by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Phase I and pharmacokinetic trial of weekly CPT-11

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Reversed-phase high-performance liquid chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Simultaneous determination of the lactone and carboxylate forms of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in rat plasma by high performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Simultaneous determination of the lactone and carboxylate forms of the camptothecin derivative CPT-11 and its metabolite SN-38 in plasma by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

High-performance liquid chromatographic analysis of the new antitumour drug SK&F 104864-A (NSC 609699) in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

High-performance liquid chromatographic determination of the novel antitumour drug topotecan and topotecan as the total of the lactone plus carboxylate forms, in human plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

The impact of column temperature in the high performance liquid chromatographic analysis of topotecan in rat and dog plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Sensitive high-performance liquid chromatographic fluorescence assay for the quantitation of topotecan (SKF 104864-A) and its lactone ring-opened product (hydroxy acid) in human plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Reversed-phase high-performance liquid chromatography method for the simultaneous quantitation of the lactone and carboxylate forms of the novel natural product anticancer agent 10-hydroxycamptothecin in biological fluids and tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Plasma pharmacokinetics of lactone and carboxylate forms of 20(S)-camptothecin in anesthetized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

High-performance liquid chromatographic analysis of the antitumour drug camptothecin and its lactone ring-opened form in rat plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

High-performance liquid chromatographic analysis of the lactone and carboxylate forms of a topoisomerase I inhibitor (the antitumor drug GI147211) in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

High-performance liquid chromatographic analysis of the investigational anticancer drug 9-aminocamptothecin, as the lactone form and as the total of the lactone and the hydroxycarboxylate forms, in micro-volumes of human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Sensitive high-performance liquid chromatographic method for the determination of the lactone form and the lactone plus hydroxy-acid forms of the new camptothecin derivative DX-8951 in human plasma using fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

High-Performance liquid chromatographic analysis of lactone and hydroxy acid of new antitumor drug, DX-8951 (exatecan), in mouse plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

High-performance liquid chromatographic quantitation of total and lactone 20(S)camptothecin in patients receiving oral 20(S)camptothecin

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Determination of GI147211 in human blood by HPLC with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Determination of the lactone and lactone plus carboxylate forms of 9-aminocamptothecin in human plasma by sensitive high-performance liquid chromatography with fluorescence detection.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

High-performance liquid chromatographic determination of irinotecan (CPT-11) and its active metabolite (SN-38) in human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

High-performance liquid chromatographic method for the simultaneous determination of the camptothecin derivative irinotecan hydrochloride, CPT-11, and its metabolites SN-38 and SN-38 glucuronide in rat plasma with a fully automated on-line solid-pha

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Simple and rapid determination of irinotecan and its metabolite SN-38 in plasma by high-performance liquid-chromatography: application to clinical pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Trace analysis of SN-38 in human plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Femtomole quantitation of 7-ethyl-10-hydroxycamptothecine (SN-38) in plasma samples by reversed-phase high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Determination of MAG-camptothecin, a new polymer-bound camptothecin derivative, and free camptothecin in dog plasma by HPLC with fluorimetric detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Liposomal lurtotecan (NX211): determination of total drug levels in human plasma and urine by reversed-phase high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

The detection of photodegradation products of irinotecan (CPT-11, Campto, Camptosar), in clinical studies, using high-performance liquid chromatography/atmospheric pressure chemical ionisation/mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Sensitive determination of irinotecan (CPT-11) and its active metabolite SN-38 in human serum using liquid chromatography-electrospray mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Validation study of assay method for DX-8951 and its metabolite in human plasma and urine by high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Fluorescence detection of the anticancer drug topotecan in plasma and whole blood by two-photon excitation.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Development of ELISAs for irinotecan and its active metabolite SN-38.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

Determination of topotecan by ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4347%2801%2900380-2

7 January 2021

10.1016/S0378-4347(01)00380-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11817043%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

1 reference